(MedPage Today) — Also, Congress lashes out at VA for unmerited bonuses
ZEISS Presents Innovations That Support Ophthalmologists in Their Work
JENA, Germany & LAS VEGAS–(BUSINESS WIRE)–ZEISS presents innovations that support ophthalmologists in their work;
At the 2015 Annual Meeting of the American Academy of Ophthalmology (AAO) in Las Vegas, ZEISS announces innovations
New High Resolution Fundus Cameras VISUCAM 224 / 524 for More Confident Diagnosis
JENA, Germany & LAS VEGAS–(BUSINESS WIRE)–New high resolution Fundus Cameras VISUCAM 224 / 524 for more confident diagnosis; ZEISS introduces a new generation of high resolution Fundus cameras at the American Academy of Ophthalmology
Uncategorized
VIDEO: DigiSight partners with ASCRS, Himalayan Cataract Project
LAS VEGAS — At the Ophthalmology Innovation Summit, Doug Foster, CEO of DigiSight Technologies, discusses the launch of Paxos, a suite of products for remote patient care, and the company’s recently announced partnership with the American Society of Cataract and Refractive Surgery and the Himalayan Cataract Project to deploy its technology to 10 hospitals in Nepal.
Uncategorized
AAO exhibit hall fire quickly contained but damages more than 60 booths
LAS VEGAS ─ A fire in the Sands Expo Center here damaged part of the exhibit hall of the American Academy of Ophthalmology annual meeting, according to the Academy.The fire was reported at 8:15 pm Thursday. No one was injured in the fire, and the cause is under investigation.The damage was confined to about 60 exhibitor booths in Hall B, which, according to the Academy’s Twitter feed, is about 10% of all exhibits.
Uncategorized
DRCR.net Protocol S: Lucentis noninferior to panretinal photocoagulation for visual acuity
LAS VEGAS — Ranibizumab is noninferior to panretinal photocoagulation with regard to visual acuity outcomes at 2 years in patients with proliferative diabetic retinopathy, according to a study presented here.“Lucentis (ranibizumab, Genentech) should be considered a viable treatment option for people with proliferative diabetic retinopathy, especially for individuals needing anti-VEGF for diabetic macular edema,” Jeffrey G. Gross, MD, said at the American Academy of Ophthalmology annual meeting.